Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Ordinary General Meeting

30 Sep 2021 09:00

RNS Number : 3878N
B&M European Value Retail S.A.
30 September 2021
 

 

 

30 September 2021

 

B&M European Value Retail S.A.

 

Notice of Ordinary General Meeting

 

B&M European Value Retail S.A. (the "Company"), the UK's leading general merchandise value retailer, announces that it has posted to shareholders today Notice of an Ordinary General Meeting of the Company.

 

The Ordinary General Meeting will be held at on Tuesday 9 November 2021 at 5, Rue Goethe, L-1637 Luxembourg, commencing at 10:00 am (CET).

 

The purpose of the Ordinary General Meeting is to propose that Paula MacKenzie be appointed as a Non-Executive Director of the Company.

 

The Notice of the Ordinary General Meeting, is available on the Company's website at www.bandmretail.com/investors/ogm.aspx

 

A summary form of the Notice of the Ordinary General Meeting is set out in Appendix 1 to this announcement.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

 

 

APPENDIX 1

 

B&M European Value Retail S.A.

Société Anonyme

Registered office: 68-70, Boulevard de la Pétrusse, L-2320 Luxembourg

Grand-Duchy of Luxembourg

R.C.S. Luxembourg: B 187275

 

Notice of the Ordinary General Meeting of B&M European Value Retail S.A. to be held at 10:00 am (CET) on Tuesday 9 November 2021 at 5, Rue Goethe, L-1637 Luxembourg.

 

AGENDA

1. To appoint Paula MacKenzie as a Director of the Company with immediate effect until the Annual General Meeting resolving on the financial statements for the financial year ended 31 March 2022.

 

Explanation of Business to be considered at the Extraordinary General Meeting

 

Resolution: Appointment of Non-Executive Director

Following the retirement of one of the four Independent Non-Executive Directors at the AGM on 29 July 2021, the Board of Directors (the "Board") of B&M European Value Retail S.A. ("B&M" or the "Company") has reduced from seven to six members. Those six members comprise the Non-Executive Chairman, two Executive Directors and three Independent Non-Executive Directors. The Board considers that there is a need to maintain a complement of at least four Non-Executive Directors, not least while the business of the Company's group continues to grow at a significant rate and also as part of succession planning generally looking to the future.

 

Following a search undertaken by Russell Reynolds Associates on behalf of the Nomination Committee of the Company and a series of interviews, the Nomination Committee has recommended that Paula MacKenzie be appointed as a Non-Executive Director to the Board of B&M. The Board has unanimously resolved to propose that Paula be appointed with immediate effect to the Board by the ordinary general meeting of shareholders of the Company.

 

Paula MacKenzie has a strong background in general management and finance. She has held a number of senior executive roles during the last 10 years with Kentucky Fried Chicken (Great Britain) Ltd ("KFC UK&I") which has over 900 stores and 27,000 employees. Her current experience leading a highly competitive multi-site business and her professional background in finance will bring additional insights and perspectives to the Board.

 

Paula has been the Managing Director of KFC for the UK and Ireland for the last four years and will be continuing in that role. Prior to that she was the Chief Financial Officer of KFC UK&I. Her experience prior to joining KFC UK&I included executive roles in finance across a variety of industry sectors with Innocent, GlaxoSmithKline and Diageo plc.

 

Notes 

 

Quorum and voting

In accordance with Article 24.6 of the Articles of Association of the Company, all decisions taken at the Meeting will be passed by a simple majority of the votes cast on each resolution, regardless of the proportion of issued ordinary share capital represented by shareholders at the Meeting. Each holder of ordinary shares has one vote in respect of each ordinary share held. As a result, the quorum for the Meeting is at least one shareholder present in person or by proxy.

 

Total voting rights

As at 29 September 2021 (being the last business day prior to the publication of this notice) the Company's issued ordinary share capital consists of 1,001,226,836 (one billion and one million and two hundred and twenty-six thousand eight hundred and thirty-six) ordinary shares, carrying one vote each. The Company holds no treasury shares, therefore the total voting rights in the Company as at 29 September 2021 is 1,001,226,836 (one billion and one million and two hundred and twenty-six thousand eight hundred and thirty-six).

 

Poll

All items in the Notice of the Meeting will be decided by a poll of shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGGCGDCRSDDGBC
Date   Source Headline
18th Jun 202610:00 amRNSBoard Retirement
18th Jun 202610:00 amRNSPublication of Annual Report and Notice of AGM
16th Jun 202612:00 pmRNSDirector/PDMR Shareholding
11th Jun 20261:00 pmRNSTiming of Q1 FY27 Trading Statement
3rd Jun 20267:00 amRNSFY26 Preliminary Results
10th Apr 20269:00 amRNSDirectorate Changes and Leadership Appointments
26th Mar 20264:45 pmRNSMajor Holding(s) in Company - TR1
24th Mar 20264:30 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:31 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:30 pmRNSMajor Holding(s) in Company - TR1
9th Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:00 amRNSAdmission of B&M Jersey Shares
2nd Mar 20268:00 amRNSReadmission - B&M European Value Retail S.A.
27th Feb 20264:48 pmRNSMigration Completion
25th Feb 202611:00 amRNSPublication of a Prospectus - Migration
24th Feb 20261:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:00 pmRNSUpdate statement on 2025 AGM voting results
22nd Jan 20267:00 amRNSQ3 FY26 Trading Statement
15th Jan 20269:00 amRNSBlock listing Interim Review
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
4th Dec 202510:00 amRNSMajor Holding in Company - TR1
28th Nov 202511:00 amRNSMajor Holding in Company - TR1
26th Nov 20259:30 amRNSMajor Holding in Company TR1
24th Nov 20252:30 pmRNSMajor Holding in Company- TR1
20th Nov 20254:00 pmRNSCEO Purchase of shares
20th Nov 202511:00 amRNSCEO Purchase of Shares
19th Nov 20259:01 amRNSCEO Purchase of Shares
19th Nov 20259:00 amRNSMajor Holding in Company TR1
18th Nov 202511:00 amRNSCEO Purchase of Shares
18th Nov 202510:58 amRNSMajor Holding in Company- TR1
14th Nov 20253:30 pmRNSMajor Holding in Company TR1
13th Nov 20257:00 amRNSFY26 Interim Results
4th Nov 20256:05 pmRNSMajor Holding in Company TR1
4th Nov 20256:00 pmRNSMajor Holding in Company TR1
30th Oct 20259:00 amRNSMajor Holding in Company TR1
28th Oct 20254:00 pmRNSMajor Holding in Company TR1
27th Oct 20251:01 pmRNSMajor Holding in Company TR1
27th Oct 20251:00 pmRNSMajor Holding in Company TR1
20th Oct 20257:00 amRNSUpdate on FY26 Guidance and Directorate Change
13th Oct 20253:30 pmRNSInformation to shareholders: statutory migration
7th Oct 20257:00 amRNSFY26 H1 Trading and Operational Update
22nd Sep 202511:30 amRNSCEO Purchase of Shares
18th Sep 20256:00 pmRNSDirector/PDMR Shareholding
15th Sep 20254:34 pmRNSCEO Purchase of Shares
11th Sep 202511:00 amRNSCEO Purchase of Shares
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20254:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.